Research Article

Perinuclear halo indicate Trichomonas vaginalis in Pap smear

Howaida Mahmoud Hagag, Yosra Hussein Alam-Eldin, Mahmoud Khalifa Mahmoud, Khadiga Ahmed Ismail*, Amany Mamdouh Abdulaziz, Ahmed Mahmoud Khalifa and Osama Mahmoud Khalifa

Published: 01/11/2019 | Volume 3 - Issue 1 | Pages: 001-005


Trichomonas vaginalis could be seen in Pap smears where it is reported, but because main concerned is placed on malignant cells in Pap smears, not much effort is done to search for this parasite in smears. In this study, 100 cervical and vaginal specimens were examined microscopically by the conventional Papanicolaou method and liquid base cytology (LBC) for the presence of Trichomonas vaginalis (T.vaginalis). 16% were infected with T.vaginalis while 10% of diagnosis based on both perinuclear halo and T. vaginalis presence although the association between perinuclear halo and T, vaginalis is statistically insignificant it is recommended to increase the number of the cases to prove or disprove the association.

Read Full Article HTML DOI: 10.29328/ Cite this Article


  1. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections. 2008; 20. Ref.:
  2. Sobel J, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis. 2001; 33: 1341-1346. Ref.:
  3. Dharma MN, Umashankar KM, Sudha AN, Kavitha G. Prevalence of the Trichomonas Vaginalis Infection in A Tertiary Care Hospital in Rural Bangalore, Southern India. J Clin Diagn Res. 2013; 7: 1401-1403. Ref.:
  4. Seña AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2004; 44: 13. Ref.:
  5. Heine P, McGregor JA. Trichomonas vaginalis: a reemerging pathogen. Clin Obstet Gynecol. 1993; 36: 137-144. Ref.:
  6. Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. Treatment of infections causad by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev. 2004; 17: 783-793. Ref.:
  7. Avwioro O. Histochemistry and tissue pathology. 2nd ed. Claverianun press Nigeria. 2010;
  8. Og A, Oe O, To A. Sensitivity of a papanicolaou smear in the diagnosis of candida albicans infection of the cervix. N Am J Med Sci. 2010; 2: 97–99. Ref.:
  9. Soper D. Trichomoniasis: under control or under controlled? Am J Obstet Gynecol. 2004; 190: 281–290. Ref.:
  10. Schwebke JR, Burgess D. Trichomoniasis. Clinical Microbiology Reviews. 2004; 17: 794–803. Ref.:
  11. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993; 85: 958–964. Ref.:
  12. Sood S, Mohanty S, Kapil A, Tolosa J, Mittal S. In Pouch TV culture for detection of Trichomonas vaginalis. Indian J Med Res. 2007; 125: 567–571. Ref.:
  13. Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, et al. Rapid Antigen Testing Compares Favorably with Transcription-Mediated Amplification Assay for the Detection of Trichomonas vaginalis in Young Women. Clin Infect Dis. 2007; 45: 194–198. Ref.: